Diabetes, Associated Clinical Spectrum, Long-term Prognosis, and Genotype/Phenotype Correlations in 201 Adult Patients With Hepatocyte Nuclear Factor 1B (HNF1B) Molecular Defects
Authors:
- Danièle Dubois-LaforgueDDDanièle Dubois-Laforgue
- for the Monogenic Diabetes Study Group of the Société Francophone du DiabèteFDfor the Monogenic Diabetes Study Group of the Société Francophone du Diabète
Open Access
- 18 April 2017
- journal article
- research article
- Published by American Diabetes Association in Diabetes Care
- Vol. 40 (11) , 1436-1443
Abstract
OBJECTIVE Molecular defects of hepatocyte nuclear factor 1B (HNF1B) are associated with a multiorgan disease, including diabetes (maturity-onset diabetes of the young 5) and kidney abnormalities. The HNF1B-syndrome is related to HNF1B mutations or to a 17q12 deletion spanning 15 genes, including HNF1B. Here, we described HNF1B-related diabetes and associated phenotypes and assessed genotype/phenotype correlations at diagnosis and in the long-term. RESEARCH DESIGN AND METHODS This multicenter retrospective cohort study included 201 patients, aged 18 or older at follow-up, with HNF1B mutations (n = 101) or deletion (n = 100). RESULTS Diabetes was present in 159 patients. At diagnosis, clinical symptoms of diabetes were present in 67 of 144 patients, and HNF1B-renal disease in 64 of 102. Although responsiveness to sulfonylureas/repaglinide was observed in 29 of the 51 tested, 111 of 140 patients (79%) were treated with insulin at follow-up. Diabetic retinopathy and/or neuropathy were present in 46 of 114 patients. Renal cysts were present in 122 of 166 patients, chronic kidney disease (CKD) stages 3–4 in 75 of 169 (44%), and end-stage renal disease (ESRD) in 36 of 169 (21%). Compared with the patients with mutations, those with HNF1B deletion had less often CKD3–4/ESRD at diagnosis (11 of 43 vs. 27 of 35, P < 10−4) and in the long-term (40 of 78 vs. 71 of 91, P = 0.0003). They were leaner and more frequently treated with insulin. CONCLUSIONS In patients with HNF1B-syndrome, diabetes complications, cardiovascular risk factors, CKD3–4, and ESRD are highly prevalent. At diabetes diagnosis, the presence of morphological and/or functional kidney disease may help etiological diagnosis. Genotype/phenotype correlations may have implications for the care and the prognosis of these patients.Keywords
This publication has 35 references indexed in Scilit:
- HNF1B-associated renal and extra-renal disease—an expanding clinical spectrumNature Reviews Nephrology, 2014
- Diagnosis, management, and prognosis of HNF1B nephropathy in adulthoodKidney International, 2011
- Spectrum of HNF1B Mutations in a Large Cohort of Patients Who Harbor Renal DiseasesClinical Journal of the American Society of Nephrology, 2010
- Lack of pancreatic body and tail in HNF1B mutation carriersDiabetic Medicine, 2008
- Renal Phenotypes Related to Hepatocyte Nuclear Factor-1β (TCF2) Mutations in a Pediatric CohortJournal of the American Society of Nephrology, 2006
- Mutations in hepatocyte nuclear factor-1β and their related phenotypesJournal of Medical Genetics, 2005
- Renal cysts and diabetes syndrome resulting from mutations in hepatocyte nuclear factor-1Nephrology Dialysis Transplantation, 2004
- Clinical Spectrum Associated with Hepatocyte Nuclear Factor-1β MutationsAnnals of Internal Medicine, 2004
- Liver and Kidney Function in Japanese Patients With Maturity-Onset Diabetes of the YoungDiabetes Care, 1998
- Mutation in hepatocyte nuclear factor–1β gene (TCF2) associated with MODYNature Genetics, 1997